PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 45 filers reported holding PASSAGE BIO INC in Q2 2024. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,532 | -76.7% | 17,039 | -60.3% | 0.00% | -87.5% |
| Q1 2024 | $58,000 | +102.0% | 42,963 | +51.1% | 0.01% | +33.3% |
| Q4 2023 | $28,713 | +103.7% | 28,429 | +32.7% | 0.01% | +200.0% |
| Q3 2023 | $14,097 | -75.3% | 21,424 | -11.1% | 0.00% | -91.3% |
| Q2 2022 | $57,000 | -80.5% | 24,111 | -74.4% | 0.02% | -82.0% |
| Q1 2022 | $292,000 | +78.0% | 94,309 | +659.5% | 0.13% | +132.7% |
| Q2 2021 | $164,000 | – | 12,417 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,026,417 | $3,197,780 | 4.14% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,983,850 | 2.41% |
| Lynx1 Capital Management LP | 5,057,629 | $4,016,769 | 1.45% |
| Vestal Point Capital, LP | 6,052,000 | $4,806,498 | 0.36% |
| Acuitas Investments, LLC | 471,812 | $374,713 | 0.20% |
| Orbimed Advisors | 10,124,576 | $8,040,938 | 0.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $1,191,300 | 0.12% |
| Affinity Asset Advisors, LLC | 264,266 | $209,880 | 0.02% |
| DLK Investment Management, LLC | 64,000 | $50,829 | 0.02% |
| Marquette Asset Management, LLC | 85,500 | $67,905 | 0.01% |